Skip to main content

Advertisement

Articles

Page 2 of 8

  1. Multiple technologies, procedures and programs call for fairly-based decisions for prioritization of healthcare interventions. There is a diversity of perspectives of what constitutes a legitimate decision, wh...

    Authors: Mireille M. Goetghebeur and Marjo S. Cellier

    Citation: Cost Effectiveness and Resource Allocation 2018 16(Suppl 1):54

    Content type: Review

    Published on:

    This article is part of a Supplement: Volume 16 Supplement 1

  2. Decision making in health requires the use of sound evidence and context-specific information, guided by a priority setting methodology or framework. For noncommunicable disease (NCD) prevention and control, a...

    Authors: Silvana Luciani and Anselm Hennis

    Citation: Cost Effectiveness and Resource Allocation 2018 16(Suppl 1):53

    Content type: Commentary

    Published on:

    This article is part of a Supplement: Volume 16 Supplement 1

  3. Priority setting in a climate of diverse needs and limited resources is one of the most significant challenges faced by health care policymakers. This paper develops and applies a comprehensive multi-criteria ...

    Authors: Rashmi Dayalu, Elizabeth T. Cafiero-Fonseca, Victoria Y. Fan, Heather Schofield and David E. Bloom

    Citation: Cost Effectiveness and Resource Allocation 2018 16(Suppl 1):52

    Content type: Research

    Published on:

    This article is part of a Supplement: Volume 16 Supplement 1

  5. This comment argues that four critical questions needs to be resolved before MCDA tools can improve priority setting in health: how to merge the quantitative and deliberative elements of MCDA; how to select cr...

    Authors: Ole F. Norheim

    Citation: Cost Effectiveness and Resource Allocation 2018 16(Suppl 1):44

    Content type: Commentary

    Published on:

    This article is part of a Supplement: Volume 16 Supplement 1

  6. Multicriteria decision analysis (MCDA) has the potential to bring more structure and transparency to health technology assessment (HTA). The objective of this paper is to highlight key methodological and pract...

    Authors: Kevin Marsh, Praveen Thokala, Sitaporn Youngkong and Kalipso Chalkidou

    Citation: Cost Effectiveness and Resource Allocation 2018 16(Suppl 1):43

    Content type: Review

    Published on:

    This article is part of a Supplement: Volume 16 Supplement 1

  7. Rotavirus (RV) diarrhea is the most common cause of severe diarrhea in children worldwide and since 2006, vaccines have been available and recommended by WHO for use in all children. We developed protocols tha...

    Authors: Roger I. Glass

    Citation: Cost Effectiveness and Resource Allocation 2018 16(Suppl 1):42

    Content type: Commentary

    Published on:

    This article is part of a Supplement: Volume 16 Supplement 1

  8. Preference-based social welfare functions (pbSWF) perform better at reconciling competing personal and social goals than typical forms of MCDA. Its virtues are (a) its respect for people’s own judgments about ...

    Authors: J. P. Sevilla

    Citation: Cost Effectiveness and Resource Allocation 2018 16(Suppl 1):41

    Content type: Commentary

    Published on:

    This article is part of a Supplement: Volume 16 Supplement 1

  9. This brief perspective highlights the importance of decision maker buy-in and ownership through stakeholder engagement in the co-construction of the multi-criteria decision analysis (MCDA) model. A brief histo...

    Authors: Praveen Thokala and Guruprasad Madhavan

    Citation: Cost Effectiveness and Resource Allocation 2018 16(Suppl 1):0

    Content type: Commentary

    Published on:

    This article is part of a Supplement: Volume 16 Supplement 1

  10. The costs for treating coronary artery disease (CAD) are high worldwide. We performed a prespecified analyses of cost-effectiveness of three therapeutic strategies for multivessel CAD.

    Authors: Sara Michelly Gonçalves Brandão, Paulo Cury Rezende, Hans-Peter Brunner-La Rocca, Yang Ting Ju, Antonio Carlos Pedroso de Lima, Myrthes Emy Takiuti, Whady Hueb and Edimar Alcides Bocchi

    Citation: Cost Effectiveness and Resource Allocation 2018 16:55

    Content type: Review

    Published on:

  11. Following the adoption of the Global Action Plan for the Prevention and Control of NCDs 2013–2020, an update to the Appendix 3 of the action plan was requested by Member States in 2016, endorsed by the Seventi...

    Authors: Ambinintsoa H. Ralaidovy, Chaitra Gopalappa, André Ilbawi, Carel Pretorius and Jeremy A. Lauer

    Citation: Cost Effectiveness and Resource Allocation 2018 16:38

    Content type: Research

    Published on:

  12. While the world has made much global progress toward the reduction of new HIV infections, HIV continues to be an important public health problem. In the face of constantly constrained resources, donors and gra...

    Authors: S. Bautista-Arredondo, N. Nance, A. Salas-Ortiz, D. Akeju, A. G. Oluwayinka, I. Ezirim, J. Anenih, C. Chima, O. Amanze, G. Omoregie, K. Ogungbemi and S. H. Aliyu

    Citation: Cost Effectiveness and Resource Allocation 2018 16:37

    Content type: Study Protocol

    Published on:

  13. Respiratory Medication Therapy Adherence Clinic (RMTAC) is an initiative by the Ministry of Health (MOH) Malaysia to improve patients’ medication adherence, as an adjunct to the usual physician care (UC). This...

    Authors: Yee Vern Yong and Asrul Akmal Shafie

    Citation: Cost Effectiveness and Resource Allocation 2018 16:36

    Content type: Research

    Published on:

  14. Specialist palliative care in the hospital addresses a heterogeneous patient population with complex care needs. In Germany, palliative care patients are classified based on their primary diagnosis to determin...

    Authors: Christian Becker, Reiner Leidl, Eva Schildmann, Farina Hodiamont and Claudia Bausewein

    Citation: Cost Effectiveness and Resource Allocation 2018 16:35

    Content type: Research

    Published on:

  15. The choice of cost data sources is crucial, because it influences the results of cost studies, decisions of hospital managers and ultimately national directives of policy makers. The main objective of this stu...

    Authors: Abdelbaste Hrifach, Christell Ganne, Sandrine Couray-Targe, Coralie Brault, Pascale Guerre, Hassan Serrier, Hugo Rabier, Gwen Grguric, Pierre Farge and Cyrille Colin

    Citation: Cost Effectiveness and Resource Allocation 2018 16:34

    Content type: Methodology

    Published on:

  16. Midostaurin (MIDO) has been proposed for the treatment of newly-diagnosed adult patients with FMS-like tyrosine kinase 3 mutation-positive (FLT3+) acute myeloid leukemia (AML) in combination with standard chem...

    Authors: Gabriel Tremblay, Mike Dolph, Sachin Patel, Patricia Brandt and Anna Forsythe

    Citation: Cost Effectiveness and Resource Allocation 2018 16:33

    Content type: Research

    Published on:

  17. Hypertension represents a high burden of disease in different healthcare systems. Recent guideline published in 2017 by the American Heart Association and the American College of Cardiology has generated a deb...

    Authors: Cesar Augusto Guevara-Cuellar, Victoria Eugenia Soto and María Isabel Molina-Echeverry

    Citation: Cost Effectiveness and Resource Allocation 2018 16:32

    Content type: Research

    Published on:

  18. Sufficient and sustainable financing of the health system is essential for improving the health of the community. The health systems financing of the EMR countries is facing the challenge. Assessment and ranki...

    Authors: Kimia Pourmohammadi, Payam Shojaei, Hamed Rahimi and Peivand Bastani

    Citation: Cost Effectiveness and Resource Allocation 2018 16:31

    Content type: Research

    Published on:

  19. Hepatocellular carcinoma (HCC) is a leading cause of cancer-related deaths globally. In China, sorafenib and oxaliplatin plus infusional-fluorouracil/leucovorin (FOLFOX4) are approved for the systemic treatmen...

    Authors: Shukui Qin, Eliza Kruger, Seng Chuen Tan, Shuqun Cheng, Nanya Wang and Jun Liang

    Citation: Cost Effectiveness and Resource Allocation 2018 16:29

    Content type: Research

    Published on:

  20. Human monoclonal antibody ustekinumab is a novel Crohn’s disease (CD) treatment blocking pro-inflammatory cytokines interleukin-12 and 23. The study’s objective was to assess cost-effectiveness of ustekinumab ...

    Authors: Amanda Hansson-Hedblom, Chrissy Almond, Fredrik Borgström, Indeg Sly, Dana Enkusson, Anders Troelsgaard Buchholt and Linda Karlsson

    Citation: Cost Effectiveness and Resource Allocation 2018 16:28

    Content type: Research

    Published on:

  21. Evidence on the relative costs and effects of interventions that do not consider ‘real-world’ constraints on implementation may be misleading. However, in many low- and middle-income countries, time and data s...

    Authors: Fiammetta M. Bozzani, Don Mudzengi, Tom Sumner, Gabriela B. Gomez, Piotr Hippner, Vicky Cardenas, Salome Charalambous, Richard White and Anna Vassall

    Citation: Cost Effectiveness and Resource Allocation 2018 16:27

    Content type: Research

    Published on:

  22. The current health system reforms in Kosovo aim to improve health status through universal health coverage. Risk pooling and ensuring access to necessary care without financial hardship are envisaged through c...

    Authors: Fatime Arenliu Qosaj, Guenter Froeschl, Merita Berisha, Bashkim Bellaqa and Rolf Holle

    Citation: Cost Effectiveness and Resource Allocation 2018 16:26

    Content type: Research

    Published on:

  23. A variety of mobile-based health technologies (mHealth) have been developed for use by community health workers to augment their performance. One such mHealth intervention—ReMiND program, was implemented in a ...

    Authors: Shankar Prinja, Pankaj Bahuguna, Aditi Gupta, Ruby Nimesh, Madhu Gupta and Jarnail Singh Thakur

    Citation: Cost Effectiveness and Resource Allocation 2018 16:25

    Content type: Research

    Published on:

  24. There are limited data describing the cost-effectiveness of brief interventions for substance use in resource-poor settings. Using a patient and provider perspective, this study investigates the cost-effective...

    Authors: Rebecca Dwommoh, Katherine Sorsdahl, Bronwyn Myers, Kwaku Poku Asante, Tracey Naledi, Dan J. Stein and Susan Cleary

    Citation: Cost Effectiveness and Resource Allocation 2018 16:24

    Content type: Research

    Published on:

  25. Translating prognostic and diagnostic biomarker candidates into clinical applications takes time, is very costly, and many candidates fail. It is therefore crucial to be able to select those biomarker candidat...

    Authors: Gimon de Graaf, Douwe Postmus, Jan Westerink and Erik Buskens

    Citation: Cost Effectiveness and Resource Allocation 2018 16:23

    Content type: Methodology

    Published on:

  26. Cardiovascular disease (CVD) is the leading cause of deaths globally, with greatest premature mortality in the low- and middle-income countries (LMIC). Many of these countries, especially in sub-Saharan Africa...

    Authors: Leopold Ndemnge Aminde, Noah Fongwen Takah, Belen Zapata-Diomedi and J. Lennert Veerman

    Citation: Cost Effectiveness and Resource Allocation 2018 16:22

    Content type: Review

    Published on:

  27. Previous studies have showed that the early diagnosis of threatened preterm labor decreases neonatal morbidity and mortality, avoids maternal morbidity induced by antepartum bed rest and unnecessary treatment,...

    Authors: Thomas Desplanches, Catherine Lejeune, Jonathan Cottenet, Paul Sagot and Catherine Quantin

    Citation: Cost Effectiveness and Resource Allocation 2018 16:21

    Content type: Research

    Published on:

  28. Colorectal cancer is one of the most common cancers worldwide and is associated with high mortality when detected at a later stage. There is a paucity of studies from low and middle income countries to support...

    Authors: Nelya Melnitchouk, Djøra I. Soeteman, Jennifer S. Davids, Adam Fields, Joshua Cohen, Farzad Noubary, Andrey Lukashenko, Olena O. Kolesnik and Karen M. Freund

    Citation: Cost Effectiveness and Resource Allocation 2018 16:20

    Content type: Research

    Published on:

  29. Health-care utilities differ considerably from country to country. Our objective was to examine the association of cultural values based on Hofstede’s cultural dimensions’ theory with utility values that were ...

    Authors: Jörg Mahlich, Piyameth Dilokthornsakul, Rosarin Sruamsiri and Nathorn Chaiyakunapruk

    Citation: Cost Effectiveness and Resource Allocation 2018 16:19

    Content type: Methodology

    Published on:

  30. Cost-effectiveness analysis (CEA) is frequently used as an input for guiding priority setting in health. However, CEA seldom incorporates information about trade-offs between total health gains and equity impa...

    Authors: Marie-Anne Boujaoude, Andrew J. Mirelman, Kim Dalziel and Natalie Carvalho

    Citation: Cost Effectiveness and Resource Allocation 2018 16:18

    Content type: Review

    Published on:

  31. Cost-effectiveness of once-daily umeclidinium bromide (UMEC) was compared with once-daily tiotropium (TIO) and once-daily glycopyrronium (GLY) in patients with chronic obstructive pulmonary disease (COPD) from...

    Authors: Dhvani Shah, Maurice Driessen, Nancy Risebrough, Timothy Baker, Ian Naya, Andrew Briggs and Afisi S. Ismaila

    Citation: Cost Effectiveness and Resource Allocation 2018 16:17

    Content type: Research

    Published on:

  33. Fenestrated endovascular aneurysm repair (fEVAR) is a new approach for complex abdominal aortic aneurysms, limited to a few specialist centers, with limited evidence base. We developed a cost-effectiveness dec...

    Authors: Oriana Ciani, David Epstein, Claire Rothery, Rod S. Taylor and Mark Sculpher

    Citation: Cost Effectiveness and Resource Allocation 2018 16:15

    Content type: Research

    Published on:

  34. In the light of demographic developments health promotion interventions for older people are gaining importance. In addition to methodological challenges arising from the economic evaluation of health promotio...

    Authors: Kai Huter, Katarzyna Dubas-Jakóbczyk, Ewa Kocot, Katarzyna Kissimova-Skarbek and Heinz Rothgang

    Citation: Cost Effectiveness and Resource Allocation 2018 16:14

    Content type: Review

    Published on:

  35. This study assessed the costs and cost-efficiency of a mobile cash transfer implemented in Tapoa Province, Burkina Faso in the MAM’Out randomized controlled trial from June 2013 to December 2014, using mixed m...

    Authors: Chloe Puett, Cécile Salpéteur, Freddy Houngbe, Karen Martínez, Dieynaba S. N’Diaye and Audrey Tonguet-Papucci

    Citation: Cost Effectiveness and Resource Allocation 2018 16:13

    Content type: Research

    Published on:

  36. This study aims to assess the cost-effectiveness of early physician consultation and guideline-based intervention to prevent endometriosis and/or disease progression using oral contraceptive (OC) and progestin...

    Authors: Ichiro Arakawa, Mikio Momoeda, Yutaka Osuga, Ikuko Ota and Kaori Koga

    Citation: Cost Effectiveness and Resource Allocation 2018 16:12

    Content type: Research

    Published on:

  38. Human resources are consistently cited as a leading contributor to health care costs; however the availability of internationally comparable data on health worker earnings for all countries is a challenge for ...

    Authors: Juliana Serje, Melanie Y. Bertram, Callum Brindley and Jeremy A. Lauer

    Citation: Cost Effectiveness and Resource Allocation 2018 16:10

    Content type: Research

    Published on:

  39. The objective of this work is to estimate the financial impact of increasing the monitoring period for breast cancer, which is financed by the Sistema de Protección Social en Salud (SPSS—Social Protection Syst...

    Authors: Román Rodríguez-Aguilar, José Antonio Marmolejo-Saucedo and Sonia Tavera-Martínez

    Citation: Cost Effectiveness and Resource Allocation 2018 16:9

    Content type: Research

    Published on:

  40. High pharmaceutical expenditure is one of the main concerns for policymakers worldwide. In Colombia, a middle-income country, outpatient prescription represents over 10% of total health expenditure in the mand...

    Authors: Sergio I. Prada, Victoria E. Soto, Tatiana S. Andia, Claudia P. Vaca, Álvaro A. Morales, Sergio R. Márquez and Alejandro Gaviria

    Citation: Cost Effectiveness and Resource Allocation 2018 16:8

    Content type: Research

    Published on:

  41. Many economic evaluations ignore economies of scale in their cost estimation, which means that cost parameters are assumed to have a linear relationship with the level of production. Economies of scale is the ...

    Authors: Thanthima Suwanthawornkul, Naiyana Praditsitthikorn, Wantanee Kulpeng, Manuel Alexander Haasis, Anna Melissa Guerrero and Yot Teerawattananon

    Citation: Cost Effectiveness and Resource Allocation 2018 16:7

    Content type: Methodology

    Published on:

  42. In Korea, hepatitis B virus (HBV) infection accounts for approximately 65–75% of HBV-related diseases, such as chronic hepatitis and liver cancer, and mother-to-child transmission is presumed to be a major sou...

    Authors: Donghoon Lee, Hyun-Young Shin and Sang Min Park

    Citation: Cost Effectiveness and Resource Allocation 2018 16:6

    Content type: Research

    Published on:

  43. All health care systems in the world struggle with rising costs for drugs. We sought to explore factors impacting on prescribing costs in a nationwide database of ambulatory care in Germany. Factors identified...

    Authors: O. Hirsch, M. Schulz, M. Erhart and N. Donner-Banzhoff

    Citation: Cost Effectiveness and Resource Allocation 2018 16:5

    Content type: Research

    Published on:

  44. Use of malaria rapid diagnostic test (mRDT) enhances patient management and reduces costs associated with the inappropriate use of antimalarials. Despite its proven clinical effectiveness, mRDT is not readily ...

    Authors: Theresa Tawiah, Keziah Malam, Anthony Kwarteng, Constance Bart-Plange, Lawrence Febir, Vivian Aubyn, Konrad Obermann, Seth Owusu-Agyei and Kwaku Poku Asante

    Citation: Cost Effectiveness and Resource Allocation 2018 16:4

    Content type: Research

    Published on:

  45. A significant minority of asthma patients remain uncontrolled despite the use of inhaled corticosteroids (ICS) and long-acting beta-agonists (LABA). A number of add-on therapies, including monoclonal antibodie...

    Authors: Zafar Zafari, Mohsen Sadatsafavi and J. Mark FitzGerald

    Citation: Cost Effectiveness and Resource Allocation 2018 16:3

    Content type: Research

    Published on:

  46. Due to its epidemiological relevance, several studies have been performed to assess the cost-effectiveness of diagnostic tests and treatments in colorectal cancer (CRC) patients.

    Authors: Annamaria Guglielmo, Nicoletta Staropoli, Monica Giancotti and Marianna Mauro

    Citation: Cost Effectiveness and Resource Allocation 2018 16:2

    Content type: Review

    Published on:

  47. The overuse of antibiotics has been identified as a major challenge in regard to the rational prescription of medicines in low and middle income countries. Extensive studies on the effectiveness of persuasive ...

    Authors: Yuqing Tang, Chaojie Liu, Zinan Zhang and Xinping Zhang

    Citation: Cost Effectiveness and Resource Allocation 2018 16:1

    Content type: Research

    Published on:

  48. To date no one has examined the quality of life and direct costs of care in treating early stage breast cancer with adjunct intraoperative radiation therapy (IORT) versus external beam radiation therapy (EBRT)...

    Authors: Rakesh Patel, Olga Ivanov and Jeff Voigt

    Citation: Cost Effectiveness and Resource Allocation 2017 15:22

    Content type: Research

    Published on:

  49. Estimating health care costs, either in the context of understanding resource utilization in the implementation of a health plan, or in the context of economic evaluation, has become a common activity of healt...

    Authors: Melanie Y. Bertram, Karin Stenberg, Callum Brindley, Jina Li, Juliana Serje, Rory Watts and Tessa Tan-Torres Edejer

    Citation: Cost Effectiveness and Resource Allocation 2017 15:21

    Content type: Methodology

    Published on:

  50. Anti-tumor necrosis factor (anti-TNF) agents are an effective, but costly, treatment for spondyloarthritis (SpA). Worldwide, multiple sets of access criteria aim to restrict anti-TNF therapy to patients with s...

    Authors: Stephanie Harvard, Daphne Guh, Nick Bansback, Pascal Richette, Alain Saraux, Bruno Fautrel and Aslam Anis

    Citation: Cost Effectiveness and Resource Allocation 2017 15:20

    Content type: Research

    Published on:

Submit manuscript

Annual Journal Metrics

Advertisement

Cost Effectiveness and Resource Allocation

ISSN: 1478-7547

Contact us